Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates
ABSTRACT Pharmacogenomics (PGx) can potentially tailor medication prescriptions to the genetic profiles of individuals, enhancing treatment outcomes and minimizing adverse drug reactions. This study assessed cardiovascular disease (CVD) patients' knowledge and views toward PGx testing in the Un...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Clinical and Translational Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/cts.70300 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227184125771776 |
|---|---|
| author | Maram O. Abbas Azhar T. Rahma Iffat Elbarazi Bassam R. Ali George P. Patrinos Farah Nagy Alya Osman Reem K. Alneyadi Anwar S. Alshamsi Mohamed Alraqabani Zeina Al‐Mahayri Fatma Al‐Maskari |
| author_facet | Maram O. Abbas Azhar T. Rahma Iffat Elbarazi Bassam R. Ali George P. Patrinos Farah Nagy Alya Osman Reem K. Alneyadi Anwar S. Alshamsi Mohamed Alraqabani Zeina Al‐Mahayri Fatma Al‐Maskari |
| author_sort | Maram O. Abbas |
| collection | DOAJ |
| description | ABSTRACT Pharmacogenomics (PGx) can potentially tailor medication prescriptions to the genetic profiles of individuals, enhancing treatment outcomes and minimizing adverse drug reactions. This study assessed cardiovascular disease (CVD) patients' knowledge and views toward PGx testing in the United Arab Emirates (UAE). A cross‐sectional study was conducted among CVD patients attending multiple clinics using a validated, culturally adapted, and piloted bilingual questionnaire. Participants were invited via phone calls or in‐person contact at clinics. Data analysis was conducted using SPSS V.29, incorporating descriptive statistics and multivariable logistic regression. A total of 425 responses were analyzed; 67.5% were over 50 years old, and 67.5% held a bachelor's degree. Chronic diseases, excluding CVD, affected 65.2%, with 58.1% reporting medication side effects and 36.5% was hospitalized due to these effects. Knowledge varied, with 55.3% demonstrating good knowledge; 75.3% recognized DNA as gene‐based, while 47.5% understood PGx for predicting medication responses. Participants were grouped into three PGx perception clusters: Cluster 1 (33.17%) concerned about risks but valued PGx, Cluster 2 (40.23%) worried about privacy/costs, and Cluster 3 (26.58%) confident in PGx benefits. Safety was the top priority for 60.2% of respondents, 34.8% would not pay for PGx tets, and 35.3% preferred preemptive testing. Regression linked higher PGx knowledge to females, non‐healthcare workers, those with genetic diseases, and those hospitalized for side effects (p < 0.05). The study highlights a need for educational initiatives in the UAE to improve PGx literacy among CVD patients. The findings suggest that targeted awareness campaigns, policy interventions addressing privacy, and financial support could promote PGx wider adoption. |
| format | Article |
| id | doaj-art-dba33c9fde9d48ea96a1448b20a875c6 |
| institution | Kabale University |
| issn | 1752-8054 1752-8062 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Translational Science |
| spelling | doaj-art-dba33c9fde9d48ea96a1448b20a875c62025-08-23T17:10:42ZengWileyClinical and Translational Science1752-80541752-80622025-08-01188n/an/a10.1111/cts.70300Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab EmiratesMaram O. Abbas0Azhar T. Rahma1Iffat Elbarazi2Bassam R. Ali3George P. Patrinos4Farah Nagy5Alya Osman6Reem K. Alneyadi7Anwar S. Alshamsi8Mohamed Alraqabani9Zeina Al‐Mahayri10Fatma Al‐Maskari11Institute of Public Health, College of Medicine and Health Sciences United Arab Emirates University Al Ain UAEInstitute of Public Health, College of Medicine and Health Sciences United Arab Emirates University Al Ain UAEInstitute of Public Health, College of Medicine and Health Sciences United Arab Emirates University Al Ain UAEDepartment of Genetics and Genomics, College of Medicine and Health Sciences United Arab Emirates University Al Ain UAEDepartment of Genetics and Genomics, College of Medicine and Health Sciences United Arab Emirates University Al Ain UAEDepartment of Pharmacy Practice Dubai Pharmacy College Dubai UAEDepartment of Pharmacy Practice Dubai Pharmacy College Dubai UAEInstitute of Public Health, College of Medicine and Health Sciences United Arab Emirates University Al Ain UAEInstitute of Public Health, College of Medicine and Health Sciences United Arab Emirates University Al Ain UAERashid Hospital Dubai Health Authority Dubai UAECollege of Health Sciences Abu Dhabi University Abu Dhabi UAEInstitute of Public Health, College of Medicine and Health Sciences United Arab Emirates University Al Ain UAEABSTRACT Pharmacogenomics (PGx) can potentially tailor medication prescriptions to the genetic profiles of individuals, enhancing treatment outcomes and minimizing adverse drug reactions. This study assessed cardiovascular disease (CVD) patients' knowledge and views toward PGx testing in the United Arab Emirates (UAE). A cross‐sectional study was conducted among CVD patients attending multiple clinics using a validated, culturally adapted, and piloted bilingual questionnaire. Participants were invited via phone calls or in‐person contact at clinics. Data analysis was conducted using SPSS V.29, incorporating descriptive statistics and multivariable logistic regression. A total of 425 responses were analyzed; 67.5% were over 50 years old, and 67.5% held a bachelor's degree. Chronic diseases, excluding CVD, affected 65.2%, with 58.1% reporting medication side effects and 36.5% was hospitalized due to these effects. Knowledge varied, with 55.3% demonstrating good knowledge; 75.3% recognized DNA as gene‐based, while 47.5% understood PGx for predicting medication responses. Participants were grouped into three PGx perception clusters: Cluster 1 (33.17%) concerned about risks but valued PGx, Cluster 2 (40.23%) worried about privacy/costs, and Cluster 3 (26.58%) confident in PGx benefits. Safety was the top priority for 60.2% of respondents, 34.8% would not pay for PGx tets, and 35.3% preferred preemptive testing. Regression linked higher PGx knowledge to females, non‐healthcare workers, those with genetic diseases, and those hospitalized for side effects (p < 0.05). The study highlights a need for educational initiatives in the UAE to improve PGx literacy among CVD patients. The findings suggest that targeted awareness campaigns, policy interventions addressing privacy, and financial support could promote PGx wider adoption.https://doi.org/10.1111/cts.70300cardiovascular diseasespatient knowledge and attitudespharmacogenomicsUnited Arab Emirates |
| spellingShingle | Maram O. Abbas Azhar T. Rahma Iffat Elbarazi Bassam R. Ali George P. Patrinos Farah Nagy Alya Osman Reem K. Alneyadi Anwar S. Alshamsi Mohamed Alraqabani Zeina Al‐Mahayri Fatma Al‐Maskari Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates Clinical and Translational Science cardiovascular diseases patient knowledge and attitudes pharmacogenomics United Arab Emirates |
| title | Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates |
| title_full | Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates |
| title_fullStr | Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates |
| title_full_unstemmed | Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates |
| title_short | Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates |
| title_sort | knowledge and views of patients with cardiovascular disease toward pharmacogenomics in the united arab emirates |
| topic | cardiovascular diseases patient knowledge and attitudes pharmacogenomics United Arab Emirates |
| url | https://doi.org/10.1111/cts.70300 |
| work_keys_str_mv | AT maramoabbas knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT azhartrahma knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT iffatelbarazi knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT bassamrali knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT georgeppatrinos knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT farahnagy knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT alyaosman knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT reemkalneyadi knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT anwarsalshamsi knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT mohamedalraqabani knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT zeinaalmahayri knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates AT fatmaalmaskari knowledgeandviewsofpatientswithcardiovasculardiseasetowardpharmacogenomicsintheunitedarabemirates |